Mereo BioPharma Group plc (NASDAQ: MREO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MEREO BIOPHARMA GROUP PLC

Mereo BioPharma Group plc (NASDAQ: MREO)
Listen to this Section


$0.32
-0.0016 ( -0.50% ) 58.6K

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Market Data


Open $0.32
Previous Close $0.32
Volume 58.6K
Market Cap $53.34M
Day Range $0.31 - $0.32
52 Week Range $0.20 - $3.05
Shares Outstanding 159.62M
Change % -0.50%
Net Change ▼ -0.0016
Insider Ownership -0.05%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2018
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -34,608.00

Date Type Amount Purchased Purchaser
2024-06-27 Sale -12990.00 Fox Christine Ann
2024-06-27 Sale -7416.00 Lewicki John A.
2024-06-27 Sale -14202.00 Sermon Charles

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 79 Nov 10, 2025
8-k 8K-related 11 Nov 10, 2025
8-k 8K-related 11 Aug 12, 2025
10-q Quarterly Reports 81 Aug 12, 2025
8-k 8K-related 10 Jul 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy